- Home
- VRDN vs BUSE Comparison
VRDN vs BUSE Comparison
Compare VRDN & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRDN | BUSE |
|---|---|---|
| Founded | 2006 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | VRDN | BUSE |
|---|---|---|
| Price | $28.69 | $28.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 7 |
| Target Price | ★ $36.20 | $31.83 |
| AVG Volume (30 Days) | ★ 2.6M | 839.2K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 3.63% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.81 |
| Revenue | $5,706,000.00 | ★ $719,584,000.00 |
| Revenue This Year | N/A | $8.68 |
| Revenue Next Year | $878.45 | $1.30 |
| P/E Ratio | ★ N/A | $24.47 |
| Revenue Growth | N/A | ★ 55.66 |
| 52 Week Low | $13.18 | $22.12 |
| 52 Week High | $34.29 | $31.70 |
Technical Indicators
Market Signals| Indicator | VRDN | BUSE |
|---|---|---|
| Relative Strength Index (RSI) | 78.24 | 41.51 |
| Support Level | $26.31 | $28.29 |
| Resistance Level | $30.79 | $29.10 |
| Average True Range (ATR) | 1.41 | 0.67 |
| MACD | 0.71 | -0.10 |
| Stochastic Oscillator | 89.65 | 9.57 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company whose subsidiaries provide retail and commercial banking services, remittance processing, and offer financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.